Phase 1 Study of Venetoclax in Combination With Decitabine 10-Day Regimen in Subjects With Acute Myeloid Leukemia
Latest Information Update: 02 Aug 2024
At a glance
- Drugs Decitabine (Primary) ; Venetoclax (Primary)
- Indications Acute myeloid leukaemia
- Focus Adverse reactions
Most Recent Events
- 30 Jul 2024 Planned primary completion date changed from 10 Jun 2024 to 10 Jun 2025.
- 30 Jul 2024 Status changed from recruiting to active, no longer recruiting.
- 12 May 2021 Planned End Date changed from 10 Jun 2024 to 10 Jun 2025.